Wednesday's ceremony marked the completion of a leading-edge, 24-bed inpatient facility at Nemours Children's Hospital, Delaware. Spanning 24,000 square feet, the first phase of the Moseley Foundation Institute features a family-centered state-of-the-art design that overlooks the beautiful gardens of the Nemours Estate to promote healing and recovery. The second phase of the Moseley Foundation Institute will feature a 19,000-square-foot outpatient Day Hospital and Infusion Center expected to open in October 2025— more than quadrupling its current size.
"Today marks a monumental milestone as we open our doors to this extraordinary facility, which will allow us to bring the very best research and clinical care to more children with cancer and blood disorders," said Mark R. Marcantano, JD, President, Nemours Children's Health, Delaware Valley. "The opening of this facility, and the continued growth as we anticipate the second phase of the project, will allow Nemours Children's to provide world-class services right here in the Delaware Valley to children with these illnesses. We are deeply grateful to the Moseley Foundation for this transformative gift."
The vision for the Moseley Foundation Institute began in March 2023 with the gift from the Moseley Foundation. As one of the most significant donations ever made to a U.S. children's hospital, the donation amplifies Nemours Children's ongoing efforts to improve both the outcome and the experience of care for children with cancer, sickle cell disease and other blood disorders. Nemours leaders anticipate both immediate and long-term benefits for patients.
"This beautiful facility bears testament to Mrs. Moseley's desire to improve children's health, and specifically to advance health outcomes related to cancer and blood disorders. I believe that she would be particularly proud of the work Nemours Children's is doing to address health disparities in the community where she was raised. We are honored that her legacy will fuel research and scholarship that will have an impact not just in Delaware, but across the country and around the world," said William J. Martin, Esq., President of the Lisa Dean Moseley Foundation.
In addition to the new inpatient facility and Day Hospital and Infusion Center, the Moseley Foundation Institute encompasses several initiatives aimed at improving clinical care and research, including:
- A Presidential Endowed Chair to support the inaugural Moseley Institute Director's work in pediatric patient care, research and other high priority areas.
- An Endowed Chair for Sickle Cell Disease Research who will further Nemours work in support of the Delaware Comprehensive Sickle Cell Research Program by conducting and overseeing sickle cell disease research. The work began in 2016 and was renewed in 2021 with a five-year, $10.5 million grant from the National Institutes of Health (NIH) Center of Biomedical Research Excellence (COBRE) to support clinical, translational and psychosocial research in sickle cell disease. The chair will also focus on reducing disparities in access to care—a key imperative as sickle cell disease disproportionately impacts minority communities. The search for this position is underway.
- An Endowed Laureate Program that will create an annual research goal for a Request for Proposals (RFP) focused on cancer and blood disorders research. The Moseley Foundation Institute will convene a Scientific Review Board to review proposals to engage and fund leading global research teams from a variety of disciplines both inside and outside of traditional laboratory research.
- An International Symposium to be held every other year to highlight the Moseley Foundation Institute's researchers' accomplishments and facilitate the exchange of information and collaboration amongst top international researchers and scholars to ultimately improve care.
"The extraordinary gift from the Moseley Foundation further empowers Nemours Children's to catapult development of new treatment options for the benefit of pediatric patients with cancer, sickle cell disease and other blood disorders," said David C. Brousseau, MD, MS, Pediatrician-in-Chief, Chair of Pediatrics at Nemours Children's Health, Delaware Valley. "We are delighted to open our doors to our first patients. We look forward to providing these patients and their families with the finest, most compassionate care."
Over the last 30 years, Nemours Children's has achieved many accolades in hematology and oncology research and care including:
- Two fully accredited transplant and cellular therapy programs supporting children with cancer, sickle cell disease and other blood disorders.
- Designation as a National Cancer Institute (NCI) Community Oncology Research Program, ranked second nationwide in enrolling children in NCI-funded trials.
- Three-fold increase in the number of patients identified to have cancer predisposition syndrome by the Cancer Genetics Program at Nemours. This program provides fully integrated and advanced molecular diagnostics for children with a personal or family history of cancer.
- Active Nemours investigator-initiated research projects in sickle cell disease that focus on novel diagnostic tools, research approaches and intervention strategies to mitigate the effects of racism and stigma on disease management.
To learn more about how this gift will impact the future of care for kids with cancer and blood disorders, please visit: nemours.org/moseleyinstitute.
About Nemours Children's Health
Nemours Children's Health is one of the nation's largest multistate pediatric health systems, which includes two freestanding children's hospitals and a network of more than 70 primary and specialty care practices. Nemours Children's seeks to transform the health of children by adopting a holistic health model that utilizes innovative, safe, and high-quality care, while also addressing children's needs well beyond medicine. In producing the highly acclaimed, award-winning pediatric medicine podcast Well Beyond Medicine, Nemours underscores that commitment by featuring the people, programs and partnerships addressing whole child health. Nemours Children's also powers the world's most-visited website for information on the health of children and teens, Nemours KidsHealth.org.
The Nemours Foundation, established through the legacy and philanthropy of Alfred I. duPont, provides pediatric clinical care, research, education, advocacy, and prevention programs to the children, families and communities it serves. For more information, visit Nemours.org.
About the Lisa Dean Moseley Foundation
Based in Wilmington, Delaware, the Lisa Dean Moseley Foundation is a non-profit organization that supports basic medical and scientific research. The Foundation generally accomplishes these goals by collaborating with and funding research and clinical programs undertaken by highly qualified organizations such as Nemours Children's Health, the American Cancer Society, the Helen Graham Cancer Center, and the Cleveland Clinic (among many other research institutions supported by previous grants made by the Foundation).
The Lisa Dean Moseley Foundation strives to support groundbreaking research and clinical programs with the goal of improving outcomes and saving patient lives.
SOURCE Nemours Children’s Health
Share this article